Maven Securities LTD Amicus Therapeutics, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $563,048 - $762,756	-64,422 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $561,115 - $690,603	64,422 New	64,422 $634,000
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $475,676 - $1.23 Million	-51,704 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $696,452 - $1.29 Million	51,704 New	51,704 $1.2 Million

273

325M

841K

353K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.81B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.